Strategic Healthcare Business Development and Commercial Excellence Strategy
The a4SU program supports startups and scaleups with comprehensive consulting at competitive rates, recognizing that brilliant science means nothing without commercial execution. Our business development services transform innovative products and ideas into market successes.
We help healthcare companies navigate the complex path from clinical and manufacturing development to regulatory approval and revenue generation. Strategic business development it’s about building sustainable commercial models and partnerships that create lasting value.
Business Development Services
Our business development approach integrates seamlessly with market access expertise, regulatory affairs, and medical affairs capabilities across our team, ensuring comprehensive commercial strategies that address all critical success factors.
Scouting of Commercial Partners
We facilitate the research and identification of potential business partners, drafting and negotiating relevant agreements. We leverage extensive networks to identify distribution partners, co-promotion opportunities, regional licensing candidates, and strategic collaborators.
Our pharmaceutical background enables us to assess partner capabilities realistically, structure successful agreements, and negotiate terms that balance risk and reward appropriately. We introduce parties and architect successful partnerships.
New Product Development
We help you with portfolio candidates identification and selection, product sales forecasts and NPV models, product development and life cycle management strategy. We also help you prioritizing pipeline investments based on realistic commercial potential.
Our approach integrates market size analysis, competitive landscape assessment, pricing potential evaluation, and reimbursement probability, producing realistic forecasts that guide resource allocation and investor communications.
02
Market Analysis & Competitive Intelligence
Existing portfolio strategy evaluation, assets evaluation and LCM strategy, therapy areas and franchise strategy, competitors analysis, differentiation strategy. We provide healthcare market analysis that goes beyond surface demographics to understand prescriber behavior, payer dynamics, and patient pathways.
For competitive intelligence, we track competitor pipelines, pricing strategies, market access approaches, and promotional tactics, identifying opportunities and threats.
Market Expansion & Forecasting
BD and in-licensing strategy, products screening and identification, in-licensing candidates valuation and commercial forecasting, due diligence and acquisition process support. We help you expand geographically and therapeutically through organic growth and strategic acquisitions.
Our forecasting methodology accounts for regulatory timelines, market access hurdles, competitive responses, and adoption curves, producing scenarios that stress-test assumptions and inform capital allocation decisions.
04
Product Launch Excellence
Comprehensive pharma product launch planning covering positioning, messaging, channel strategy, sales force deployment, key opinion leader engagement, and performance monitoring. We apply pharmaceutical industry best practices scaled appropriately for startup resources.
Successful launches require cross-functional coordination across regulatory, medical affairs, market access, commercial, and operations. We provide the strategic framework and tactical playbooks that align these functions toward common objectives.
05
Andrea brings over 30 years of global experience spanning clinical development, technical operations, and commercial leadership. He has held executive and board-level roles in both public and privately held pharmaceutical companies, guiding global strategies from product development through market expansion.
His career began in clinical pharmacology and advanced through pharmaceutical technology and plant management before spending recent decades shaping commercial growth as Group Chief Commercial Officer and Board Member. During this time, Andrea successfully led execution of more than 100 licensing and sales partnerships, delivering multi-billion-dollar revenue impact across international markets.
Known for strategic vision and operational insight, Andrea brings deep expertise in forging commercial alliances, navigating regulatory environments, and scaling business models in the healthcare sector. His hands-on experience building distribution networks, negotiating complex partnerships, and launching products across diverse markets makes him uniquely qualified to guide business development strategy.
Andrea maintains active membership in several global pharmaceutical organizations and formerly served as President of the Associazione Farmaceutici Ticinese (AFTI), providing access to extensive industry networks that benefit client partner scouting and alliance building.
Beyond industry, Andrea demonstrates longstanding commitment to education and social impact as one of the founders and former board member of Everest Academy in Lugano, Switzerland, and contributor to educational initiatives in Brazil through the Betania Franciscan Fraternity.
He holds a Doctorate in Pharmaceutical Chemistry and Pharmacy from the University of Pavia, a Postdoctoral fellowship in Clinical Pharmacology from San Matteo Hospital, and a Master of Business degree from London, UK.
Whether you’re identifying your first distribution partner or negotiating a strategic licensing deal, Andrea provides seasoned guidance that bridges scientific innovation with commercial execution, helping you building partnerships that accelerate market success.